178 results on '"Page, Stephen W."'
Search Results
2. Physicochemical properties of otic products for Canine Otitis Externa: comparative analysis of marketed products
3. Development and validation of a new analytical method for estimation of narasin using refractive index detector and its greenness evaluation
4. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model
5. Aminoguanidines: New leads for treatment of Giardia duodenalis infection
6. In vitro antimicrobial activity of monensin against common clinical isolates associated with canine otitis externa
7. Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel
8. The effect of doxapram on survival and APGAR score in newborn puppies delivered by elective caesarean: A randomized controlled trial
9. Nanotechnology and narasin: a powerful combination against acne.
10. Advanced Strategies of Drug Delivery via Oral, Topical, and Parenteral Administration Routes: Where Do Equine Medications Stand?
11. Key Considerations in Designing Oral Drug Delivery Systems for Dogs
12. Antimicrobial Stewardship in Veterinary Medicine
13. Antigiardial Activity of Novel Guanidine Compounds
14. In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens
15. Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals.
16. Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model
17. The publication of studies involving the use of human critically important antimicrobial agents in veterinary species: Reply from the authors
18. Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci
19. Benzalkonium chloride intoxication in cats
20. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens
21. Comparison of Two Transmission Electron Microscopy Methods to Visualize Drug-Induced Alterations of Gram-Negative Bacterial Morphology
22. Development and Validation of a New Analytical Method for Estimation of Narasin Using Refractive Index Detector and its Greenness Evaluation
23. Semisynthesis and biological evaluation of a focused library of unguinol derivatives as next-generation antibiotics
24. In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice
25. In vitro efficacy and pharmacodynamic profiles of four polyether ionophores against methicillin‐resistant Staphylococcus spp.
26. Antibiotic use in animals and humans in Australia
27. In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa
28. Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants
29. Discovery of 4,6‐bis(2‐(( E )‐benzylidene)hydrazinyl)pyrimidin‐2‐Amine with Antibiotic Activity
30. In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens
31. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa
32. Gram‐Positive and Gram‐Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues
33. Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review
34. In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa.
35. Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing
36. Repurposing Ionophores as novel antimicrobial agents for the treatment of bovine mastitis caused by Gram‐positive pathogens
37. Giardia duodenalis mouse model for the development of novel antigiardial agents
38. In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa
39. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent
40. In vitrocomparison of the dermal penetration of three different topical formulations containing lasalocid
41. Development of Intramammary Drug Delivery Systems: Novel In Vitro Release Method
42. Robenidine Analogues as Gram-Positive Antibacterial Agents
43. <italic>In vitro</italic> antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa.
44. In vitro comparison of the dermal penetration of three different topical formulations containing lasalocid.
45. LETTERS LETTERS.
46. Development of intramammary delivery systems containing lasalocid for the treatment of bovine mastitis: impact of solubility improvement on safety, efficacy, and milk distribution in dairy cattle.
47. Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections.
48. Antibiotic use in animals and humans in Australia.
49. Antibiotic Awareness Week - November 2017: Veterinary Surgeons - Leaders in Antimicrobial Stewardship?
50. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.